There were 1,923 press releases posted in the last 24 hours and 399,241 in the last 365 days.

SHAREHOLDER ALERT: WeissLaw LLP Reminds CISN, AXE, MDCO, and WLH Shareholders About Its Ongoing Investigations

NEW YORK, Dec. 24, 2019 (GLOBE NEWSWIRE) --

If you own shares in any of the companies listed above and
would like to discuss our investigations or have any questions concerning
this notice or your rights or interests, please contact:

Joshua Rubin, Esq.
WeissLaw LLP
1500 Broadway, 16th Floor
New York, NY  10036
(212) 682-3025
(888) 593-4771
stockinfo@weisslawllp.com

Cision, Ltd. (NYSE: CISN)

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Cision, Ltd. (NYSE: CISN) in connection with the proposed acquisition of the Company by an affiliate of Platinum Equity.  Under the terms of the acquisition agreement, CISN shareholders will receive $10.00 in cash for each CISN share that they own.  If you own CISN shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: http://www.weisslawllp.com/cision-ltd/

Anixter International, Inc. (NYSE: AXE)

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Anixter International, Inc. (NYSE: AXE) in connection with the proposed acquisition of the Company by an affiliate of Clayton, Dubilier & Rice.  Under the terms of the acquisition agreement, AXE shareholders will receive $81.00 in cash for each AXE share that they own.  If you own AXE shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: http://www.weisslawllp.com/anixter-international-inc/

The Medicines Co. (NASDAQ: MDCO)

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of The Medicines Co. (NASDAQ: MDCO) in connection with the proposed acquisition of the Company by Swiss pharmaceutical company Novartis International A.G.  Under the terms of the acquisition agreement, MDCO shareholders will receive $85.00 in cash for each CISN share that they own.  If you own MDCO shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: http://www.weisslawllp.com/the-medicines-co/

William Lyon Homes (NYSE: WLH)

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of William Lyon Homes (NYSE: WLH) in connection with the proposed acquisition of the Company by Taylor Morrison Home Corp. (NYSE: TMHC) (“TMHC”).  Under the terms of the acquisition agreement, WLH shareholders will receive 0.80 shares of TMHC and $2.50 in cash for each WLH share that they own, representing implied merger consideration valued at $19.86 based on TMHC’s November 6, 2019 trading price of $21.70.  If you own WLH shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: http://www.weisslawllp.com/william-lyon-homes/

Primary Logo